Alnylam Pharmaceuticals gains FDA approval for Amvuttra in ATTR-CM, boosting revenue prospects. Click here to read an ...
Celadon Pharmaceuticals is set to delist from London's AIM after its directors resigned. The medical cannabis firm on Monday said that it will propose to move ahead with the cancellation of trading of ...
Milestone Pharmaceuticals faces a pivotal FDA PDUFA decision for etripamil in PSVT. Read here for a detailed investment ...
The "Chili Pepper Market by Product Type (Fresh Peppers, Processed Peppers), Heat Level (Extreme Heat, Hot Heat, Medium Heat), Packaging Type, End Use Industry, Distribution Channel - Global Forecast ...
Predicting drug shortages and optimising the distribution of pharmaceuticals are critical components of AI-optimised supply chain management. AI models can analyse vast amounts of data to forecast ...
Rocket Lab USA ( RKLB) is the second-most-successful space stock after SpaceX. It has launched 62 of its Electron rockets ...
Casey Fowler considers how intellectual property (IP) management will play a role in protecting pharma companies’ investments and future R&D. Protecting the process Intellectual property (IP ...
Mar. 18, 2025 — A research team has found that lecanemab was probably less effective in females than males in its Phase 3 trial. However, there was insufficient evidence to say the drug was ...
Under the agreement, Rhythm has agreed to repay $6.3 million in cash to RareStone. Rhythm also agreed to return all shares of RareStone that were acquired under the original agreement for no ...
Specific changes are needed to lower the barriers to entry for using the hospital and insurer price transparency data, ...
Read our GTA 5 Nightclub guide to learn how to purchase, manage, and make money in simple steps as both beginner or veteran.
Joshua Brown from Ritholtz Wealth Management recently talked about Pfizer ... is being treated by investors right now, it’s like a ghost. But I think ultimately this is the type of stock where ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results